Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Proglumetacin, an orally active and potent cyclo-oxygenase inhibitor, inhibits the SARS-CoV Mpro (main protease of the SARS-CoV-2) with an AC50 of 8.9 μM, indicating its potential efficacy against SARS-CoV-2. It exhibits anti-inflammatory activity, making it suitable for research into conditions like Rheumatoid arthritis and Allergic air pouch inflammation[1][2][3].
説明 | Proglumetacin, an orally active and potent cyclo-oxygenase inhibitor, inhibits the SARS-CoV Mpro (main protease of the SARS-CoV-2) with an AC50 of 8.9 μM, indicating its potential efficacy against SARS-CoV-2. It exhibits anti-inflammatory activity, making it suitable for research into conditions like Rheumatoid arthritis and Allergic air pouch inflammation[1][2][3]. |
分子量 | 844.43 |
分子式 | C46H58ClN5O8 |
CAS No. | 57132-53-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Proglumetacin 57132-53-3 Inhibitor inhibitor inhibit